HIV infectious disease

Related records

Broader conditions (12)

• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Disease of primarily extrinsic mechanism
• Human disease
• Infectious disease
• Lentivirus infection
• Primary viral infectious disease
• Reproductive system disorder
• Sexually transmitted disease
• Viral infectious disease
• Viral sexually transmitted disease

Narrower conditions (5)

• AIDS
• AIDS related complex
• Central nervous system AIDS arteritis
• Congenital human immunodeficiency virus
• HIV wasting syndrome

Trials (5,216)

• 'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor
• "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"
• "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
• "Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"
• "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"
• "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection
• "The Once A Day Protease Inhibitor Regimens"
• (mo)BETTA Trial in Transwomen for Optimization of ART
• (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
• #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
• #TranscendentHealth: A Text Messaging Pregnancy Prevention Program for Transgender Boys
• 1:1 Comparison of the Pocket Colposcope in Kenya
• 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults
• 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults
• 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
• 2000 HIV Human Functional Genomics Partnership Program
• 2000HIV Trained Innate Immunity in HIV Elite Controllers
• 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
• 2NN & CHARM Long-Term Follow-up Study
• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

Approved drugs (48)

• Abacavir sulfate
• Amprenavir
• Atazanavir sulfate
• Azithromycin
• Bictegravir sodium
• Cabotegravir
• Cabotegravir sodium
• Cobicistat
• Darunavir
• Darunavir ethanolate
• Didanosine
• Dolutegravir sodium
• Doravirine
• Efavirenz
• Elvitegravir
• Emtricitabine
• Enfuvirtide
• Epoetin alfa
• Etravirine
• Fomivirsen

Drugs in development (390)

• 1018 ISS Phase 1
• 16.ALPHA.-bromoepiandrosterone Phase 1
• Abacavir Phase 3
• Acetaminophen Phase 3
• Acetylcholine Phase 1
• Acetylcysteine Phase 1
• Acitretin Phase 1
• Acriflavine Phase 1
• Acyclovir Phase 3
• Acyclovir sodium Phase 2
• Adefovir Phase 1
• Adefovir dipivoxil Phase 3
• Agatolimod sodium Phase 1
• Albendazole Phase 3
• Albuvirtide Phase 3
• Aldesleukin Phase 3
• Alendronic acid Phase 2
• Alovudine Phase 2
• Aluminum hydroxide Phase 1
• Alvircept sudotox Phase 1

Other linked drugs (16)

• Acemannan
• AD-439
• Alcohol
• Angiotensin II
• Cimetidine
• Ditiocarb sodium
• Eplerenone
• Glutathione
• Inosine pranobex
• Methoxsalen
• Navuridine
• Palinavir
• Penciclovir
• Pentamidine
• Tenofovir
• Testosterone